Aprea Therapeutics Earnings Estimate

APRE Stock  USD 0.60  0.07  10.45%   
By analyzing Aprea Therapeutics' earnings estimates, investors can diagnose different trends across Aprea Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Aprea Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Aprea Therapeutics is projected to generate -0.49 in earnings per share on the 31st of December 2025. Aprea Therapeutics earnings estimates show analyst consensus about projected Aprea Therapeutics EPS (Earning Per Share). It derives the highest and the lowest estimates based on Aprea Therapeutics' historical volatility. Many public companies, such as Aprea Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Aprea Therapeutics' earnings estimates, investors can diagnose different trends across Aprea Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit is expected to grow to about (6.7 M). In addition to that, Pretax Profit Margin is expected to decline to -8.15Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aprea Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
For information on how to trade Aprea Stock refer to our How to Trade Aprea Stock guide.

Aprea Therapeutics Earnings per Share Projection vs Actual

About Aprea Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Aprea Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Aprea Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Aprea Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-288.9 M-274.5 M
Retained Earnings Total Equity-129.6 M-123.1 M
Earnings Yield(0.82)(0.86)
Price Earnings Ratio(1.26)(1.32)
Price Earnings To Growth Ratio 0.03  0.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Aprea Therapeutics is a strong investment it is important to analyze Aprea Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aprea Therapeutics' future performance. For an informed investment choice regarding Aprea Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aprea Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
For information on how to trade Aprea Stock refer to our How to Trade Aprea Stock guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Will Biotechnology sector continue expanding? Could Aprea diversify its offerings? Factors like these will boost the valuation of Aprea Therapeutics. If investors know Aprea will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aprea Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(2.12)
Revenue Per Share
0.08
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.42)
Return On Equity
(0.75)
Understanding Aprea Therapeutics requires distinguishing between market price and book value, where the latter reflects Aprea's accounting equity. The concept of intrinsic value - what Aprea Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Aprea Therapeutics' price substantially above or below its fundamental value.
Understanding that Aprea Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aprea Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aprea Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.